This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Singer, C. Articles by Cullen, K. J. Search for Related Content PubMed PubMed Citation Articles by Singer, C. Articles by Cullen, K. J.

Malignant Breast Epithelium Selects for Insulin-like Growth Factor II Expression in Breast Stroma: Evidence for Paracrine Function¹

Vincent T. Lombardi Cancer Research Center, Georgetown University, Washington, DC 20007 [C. S., A. R., M. E. L., K. J. C.]; Geraldine Brush Cancer Research Center, San Francisco, California 94115 [H. S. S.]; and Creighton University School of Medicine, Omaha, Nebraska 68178 [H. T. L.]

Paracrine interactions between stromal and epithelial cells are important influences on the growth and malignant behavior of breast cancers. Insulin-like growth factors I and II (IGF-I and II) are expressed by fibroblasts in benign and malignant breast lesions, and both are strong mitogens for a number of breast cancer epithelial cell lines in vitro. We have analyzed the stromal mRNA expression of IGF-I and IGF-II in matched sets of fibroblast cell lines derived from three locations in the affected breast of eight patients with breast cancer: (a) the breast tumor itself; (b) surrounding normal breast tissue; and (c) overlying breast skin.

IGF-I expression was easily detected in all fibroblasts derived from normal breast tissue. In general, lesser amounts of IGF-I mRNA were detected in fibroblasts derived from breast tumors or skin. In contrast, IGF-II expression was detected at very low levels in only 3 of 8 normal breast fibroblasts, but was present in 6 of 8 tumor fibroblasts. IGF-II mRNA was expressed in all skin fibroblasts tested.

IGF-II-negative stromal fibroblasts from normal breast, which were plated at low density and allowed to grow to confluence in the presence of MCF-7 breast tumor epithelial cells, demonstrated a marked increase in IGF-II mRNA expression. IGF-II in situ hybridization studies confirmed that IGF-II expression is seen at high levels in stroma of many invasive breast cancers but not normal breast. We conclude that paracrine influences, mediated by soluble factors released by breast tumor epithelium, are able to specifically increase expression of IGF-II in breast stroma, most likely by a process of clonal selection.

¹ Supported by NIH Grants CA 5503-01 and CA 58441-01, and United States Army Grant DAMD 17-93-J-3005.

² To whom requests for reprints should be addressed, at Division of Medical Oncology, Georgetown University Medical Center, 3800 Reservoir Road, NW, Washington, DC 20007.

Received 9/12/94. Accepted 4/ 3/95.

This article has been cited by other articles:

				G Hudelist, T Wagner, M Rosner, A Fink-Retter, D Gschwantler-Kaulich, K Czerwenka, R Kroiss, M Tea, K Pischinger, W J Kostler, et al. Intratumoral IGF-I protein expression is selectively upregulated in breast cancer patients with BRCA1/2 mutations Endocr. Relat. Cancer, December 1, 2007; 14(4): 1053 - 1062. [Abstract] [Full Text] [PDF]

				W. Li, C.-L. Wu, P. G. Febbo, and A. F. Olumi Stromally Expressed c-Jun Regulates Proliferation of Prostate Epithelial Cells Am. J. Pathol., October 1, 2007; 171(4): 1189 - 1198. [Abstract] [Full Text] [PDF]

				Y. He, O. E. Franco, M. Jiang, K. Williams, H. D. Love, I. M. Coleman, P. S. Nelson, and S. W. Hayward Tissue-Specific Consequences of Cyclin D1 Overexpression in Prostate Cancer Progression Cancer Res., September 1, 2007; 67(17): 8188 - 8197. [Abstract] [Full Text] [PDF]

				M. P.V. Shekhar, S. Santner, K. A. Carolin, and L. Tait Direct Involvement of Breast Tumor Fibroblasts in the Modulation of Tamoxifen Sensitivity Am. J. Pathol., May 1, 2007; 170(5): 1546 - 1560. [Abstract] [Full Text] [PDF]

				L. Lu, D. Katsaros, A. Wiley, I. A. Rigault de la Longrais, H. A. Risch, M. Puopolo, and H. Yu The Relationship of Insulin-Like Growth Factor-II, Insulin-Like Growth Factor Binding Protein-3, and Estrogen Receptor-{alpha} Expression to Disease Progression in Epithelial Ovarian Cancer Clin. Cancer Res., February 15, 2006; 12(4): 1208 - 1214. [Abstract] [Full Text] [PDF]

				T. L. Wise and D. D. Pravtcheva Delayed Onset of Igf2-Induced Mammary Tumors in Igf2r Transgenic Mice Cancer Res., February 1, 2006; 66(3): 1327 - 1336. [Abstract] [Full Text] [PDF]

				R. C. Hovey, J. Harris, D. L. Hadsell, A. V. Lee, C. J. Ormandy, and B. K. Vonderhaar Local Insulin-Like Growth Factor-II Mediates Prolactin-Induced Mammary Gland Development Mol. Endocrinol., March 1, 2003; 17(3): 460 - 471. [Abstract] [Full Text] [PDF]

				A. Decensi, H. Johansson, R. Miceli, L. Mariani, T. Camerini, E. Cavadini, M. G. Di Mauro, A. Barreca, A. G. Gonzaga, S. Diani, et al. Long-Term Effects of Fenretinide, a Retinoic Acid Derivative, on the Insulin-like Growth Factor System in Women with Early Breast Cancer Cancer Epidemiol. Biomarkers Prev., October 1, 2001; 10(10): 1047 - 1053. [Abstract] [Full Text] [PDF]

				A. Orimo, Y. Tomioka, Y. Shimizu, M. Sato, S. Oigawa, K. Kamata, Y. Nogi, S. Inoue, M. Takahashi, T. Hata, et al. Cancer-associated Myofibroblasts Possess Various Factors to Promote Endometrial Tumor Progression Clin. Cancer Res., October 1, 2001; 7(10): 3097 - 3105. [Abstract] [Full Text] [PDF]

				M. P. V. Shekhar, J. Werdell, S. J. Santner, R. J. Pauley, and L. Tait Breast Stroma Plays a Dominant Regulatory Role in Breast Epithelial Growth and Differentiation: Implications for Tumor Development and Progression Cancer Res., February 1, 2001; 61(4): 1320 - 1326. [Abstract] [Full Text]

				R. J. Pauley, S. J. Santner, L. R. Tait, R. K. Bright, and R. J. Santen Regulated CYP19 Aromatase Transcription in Breast Stromal Fibroblasts J. Clin. Endocrinol. Metab., February 1, 2000; 85(2): 837 - 846. [Abstract] [Full Text]

				V Gouon-Evans, M. Rothenberg, and J. Pollard Postnatal mammary gland development requires macrophages and eosinophils Development, January 6, 2000; 127(11): 2269 - 2282. [Abstract] [PDF]

				R. M. Adam, J. G. Borer, B. J. Williams, J. A. Eastham, K. R. Loughlin, and M. R. Freeman Amphiregulin Is Coordinately Expressed with Heparin-Binding Epidermal Growth Factor-Like Growth Factor in the Interstitial Smooth Muscle of the Human Prostate Endocrinology, December 1, 1999; 140(12): 5866 - 5875. [Abstract] [Full Text]

				A. F. Olumi, G. D. Grossfeld, S. W. Hayward, P. R. Carroll, T. D. Tlsty, and G. R. Cunha Carcinoma-associated Fibroblasts Direct Tumor Progression of Initiated Human Prostatic Epithelium Cancer Res., October 1, 1999; 59(19): 5002 - 5011. [Abstract] [Full Text] [PDF]

				S. C. Heffelfinger, M. A. Miller, R. Yassin, and R. Gear Angiogenic Growth Factors in Preinvasive Breast Disease Clin. Cancer Res., October 1, 1999; 5(10): 2867 - 2876. [Abstract] [Full Text] [PDF]

				E. Adriaenssens, L. Dumont, S. Lottin, D. Bolle, A. Lepretre, A. Delobelle, F. Bouali, T. Dugimont, J. Coll, and J.-J. Curgy H19 Overexpression in Breast Adenocarcinoma Stromal Cells Is Associated with Tumor Values and Steroid Receptor Status but Independent of p53 and Ki-67 Expression Am. J. Pathol., November 1, 1998; 153(5): 1597 - 1607. [Abstract] [Full Text] [PDF]

				P. Bhat-Nakshatri, T. R. Newton, R. Goulet Jr., and H. Nakshatri NF-kappa B activation and interleukin 6 production in fibroblasts by estrogen receptor-negative breast cancer cell-derived interleukin 1alpha PNAS, June 9, 1998; 95(12): 6971 - 6976. [Abstract] [Full Text] [PDF]

				M. J. Gerdes, M. Larsen, L. McBride, T. D. Dang, B. Lu, and D. R. Rowley Localization of Transforming Growth Factor-b1 and Type II Receptor in Developing Normal Human Prostate and Carcinoma Tissues J. Histochem. Cytochem., March 1, 1998; 46(3): 379 - 388. [Abstract] [Full Text]

				C. F. Singer, A. Rasmussen, M. E. Lippman, and K. J. Cullen Coexpression of Stromelysin-3 and Insulin-Like Growth Factor II in Tumors of Ectodermal, Mesodermal, and Endodermal Origin: Indicator of a Fetal Cell Phenotype J. Clin. Endocrinol. Metab., June 1, 1997; 82(6): 1917 - 1922. [Abstract] [Full Text] [PDF]

				S. J. Santner, R. J. Pauley, L. Tait, J. Kaseta, and R. J. Santen Aromatase Activity and Expression in Breast Cancer and Benign Breast Tissue Stromal Cells J. Clin. Endocrinol. Metab., January 1, 1997; 82(1): 200 - 208. [Abstract] [Full Text] [PDF]